Please login to the form below

Not currently logged in
Email:
Password:

Pollinex Quattro

This page shows the latest Pollinex Quattro news and features for those working in and with pharma, biotech and healthcare.

Allergy Tx hit hard as birch pollen product stumbles

Allergy Tx hit hard as birch pollen product stumbles

The trial started in 2017 and was designed to test the efficacy of the Pollinex Quattro Birch on the symptoms of allergic rhino-conjunctivitis due to birch pollen, as well as ... Two phase 2 studies revealed a significant 32% reduction in allergic

Latest news

  • Positive mid-stage trial gives Allergy’s investors some welcome relief Positive mid-stage trial gives Allergy’s investors some welcome relief

    All of the doses were safe and well-tolerated in the 447-patient study, according to Allergy, which was hit hard 11 years ago when the FDA placed its Pollinex Quattro

  • Leaning forward

    The company's flagship product is Pollinex Quattro, which is transforming immunotherapy by vaccinating against allergy with only four injections. ... A more structured process for classifying and resolving incidents.  . Pollinex Quattro allergy vaccine.

  • Yo-yoing

    R204, which marks an important step in the development of Pollinex Quattro for ragweed allergy.

  • Time for a tumble

    progress made in clinical trials, particularly that of lead product, Pollinex Quattro, a four-shot vaccination for allergy sufferers.

  • Hitting the highs and lows

    Allergy Therapeutics makes a hayfever vaccine Pollinex Quattro in Europe on a 'named patient basis'. ... Pollinex Quattro improves on this as the treatment is delivered in just four injections.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....